Paula Mosallaei

Paula Mosallaei

Auto-generated profile, based on publicly available information

Paula Mosallaei

Department of Ophthalmology, Faculty of Medicine and Health Technology Tampere University Tampere Finland

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 January 2025 in Quality of Life Research
Verified
Journal Article
Open access
PDF file
UAUlla Aapola
Ulla Aapola
PMPaula Mosallaei
Paula Mosallaei
JNJanika Nättinen
Janika Nättinen
ISIlona Suurkuukka
Ilona Suurkuukka
JAAKKO TUOMILEHTOJAAKKO TUOMILEHTO
JAAKKO TUOMILEHTO
HUHannu Uusitalo
Hannu Uusitalo
Purpose: To assess the relationship between quality of life (QoL) and ocular surface health within a Finnish population-based cohort. Methods: A cross-sectional study involved 601 individuals born between the years 1933–1956. Ocular surface health and dry eye disease (DED) were clinically evaluated using several diagnostic tests. Participants completed the Ocular Surface Disease Index (OSDI), QoL assessment with the 15D and Medical Outcomes Study 36-Item Short Form Health Survey (SF-36), and the Beck’s Depression Inventory (BDI-II) questionnaires. Various statistical methods were employed to explore the associations between QoL, ocular surface health, and sex disparities. Results: DED had negative impact on QoL in all participants, and especially in women. Adjusted for comorbidities, DED doubled the odds of worse health-related QoL (15D: OR = 2.31 [95% CI: 1.24–4.31, p < 0.01]) and mental health (SF-36 MCS and BDI-II: OR = 2.08 [95% CI: 1.04–4.16, p < 0.05]). Noninvasive tear break-up time (NIBUT) correlated with all QoL scores. In women, the most significant clinical signs correlating with low QoL were NIBUT (15D: r = 0.20, p = 0.002; SF-36 MCS: r = 0.18, p = 0.026), and conjunctival staining (15D: r=-0.19, p = 0.004; BDI-II: r = 0.27, p < 0.001), whereas in men, blepharitis correlated with depression score (BDI-II: r = 0.20, p = 0.036). High OSDI was associated with worse QoL in women, but not in men. Conclusion: This first population-based study assessing general QoL data with objective clinical measures of DED indicated that among elderly population, both symptoms and signs of DED independently impacted different aspects of QoL. In addition, significant sex-differences in these associations were observed and should be considered both in research settings and when assessing and treating people with DED.

27 September 2024 in Acta Ophthalmologica
Verified
Journal Article
Open access
PMPaula Mosallaei
Paula Mosallaei
PPPetri Purola
Petri Purola
LTLaura Tolkkinen
Laura Tolkkinen
MGMika Gissler
Mika Gissler
HUHannu Uusitalo
Hannu Uusitalo
Purpose: To study the changes in incidence, age at onset and severity of visual impairment (VI) due to retinitis pigmentosa (RP) in the Years 1980–2019, and the incidence and age at diagnosis of hereditary retinal dystrophy (HRD) diagnoses coded by ICD10 H35.5 in the Years 1998–2019 in Finland.Methods: A total of 1606 persons with VI due to RP registered by the Finnish Register of Visual Impairment and total of 4291 HRD diagnoses registered by the Care Register of the Finnish Institute for Health and Welfare were included. VI was classified according to the Finnish national definitions derived from the WHO definitions. The significance of the changes in incidence and age at onset were tested with statistical tests (Kruskal–Wallis, Mann–Whitney U and Cochran‐Armitage). Two‐tailed p‐value below 0.05 was considered significant.Results: The incidence of VI due to RP has decreased from 0.96/100 000 in the 1980s to 0.55/100 000 in the 2010s (p 0.004). The age at onset of VI has increased from 41.6 to 50.3 years. The severity of VI has not changed. The incidence of HRD diagnoses has decreased from 3.66/100 000 in the 2000s to 2.86/100 000 in the 2010s (p 0.024). The age at diagnosis has risen in male patients from 42.1 to 44.5 years (p 0.024).Conclusion: The VI caused by RP in Finland has decreased. It develops at an older age than in the past. We hypothesize that this trend may be attributed to informed decisions by visually impaired persons to refrain from having offspring to prevent the transmission of hereditary mutations. The severity of VI due to RP has remained relatively unchanged. The incidence of HRD diagnoses has decreased, and the diagnosis occurs at an older age among men.

2 July 2026 in Acta Ophthalmologica
Verified
Journal Article
Open access
RMRasha Sameer Moustafa
Rasha Sameer Moustafa
PMPaula Mosallaei
Paula Mosallaei
PPPetri Purola
Petri Purola
LILaura Impiö
Laura Impiö
MGMika Gissler
Mika Gissler
HUHannu Uusitalo
Hannu Uusitalo
Purpose: To investigate visual impairment (VI) associated with Usher syndrome (USH), a syndromic form of retinitis pigmentosa. Methods: This register‐based study used data from the Register of the Finnish Federation for Visual Impairment for persons registered with USH‐related VI from 1985 to 2019. Temporal trends in incidence, prevalence, recorded age at onset of VI, severity of registered VI, and sex distribution were analysed. Results: The mean annual incidence of USH–related VI remained relatively stable across decades ( p > 0.05), ranging from 0.19/100000 in 1985–1989 to 0.09/100000 in 2010–2019. In contrast, prevalence increased significantly over time ( p < 0.001), from 0.70/100000 in 1985–1989 to 2.84/100000 in 2010–2019. The mean recorded age at onset of VI remained relatively stable. A significant shift in severity distribution was observed ( p = 0.041), with fewer registrations classified as Near‐Total Blindness and Total Blindness. In the 2010s, the severity distribution of VI differed between women and men. Conclusion: As the first nationwide, long‐term register–based study of USH–related VI, this 35‐year analysis demonstrates stable incidence alongside increasing prevalence, with an observed redistribution of registered VI severity away from Near‐Total Blindness and Total Blindness. These findings reflect both the expected natural disease course and broader system‐level influences on registration patterns, underscoring the value of long‐term register data for monitoring rare disease epidemiology when interpreted in light of established clinical characteristics of USH, VI classification criteria, and the healthcare system context. Together, they support the need to refine approaches to VI classification, rehabilitation and public health planning for people with USH.